At NOVAPmedical, we’re redefining infection prevention in critical care. Our patented endotracheal tube technology targets the root cause of ventilator-associated pneumonia (VAP) — biofilm build up inside the airway. With an easy-to-remove inner liner that clears harmful biofilm without disrupting ventilation, NOVAP offers a smarter, safer solution for patients and clinicians. Built on research from Trinity College Dublin, our mission is to make every breath safer for those who need it most.
At NOVAP Medical, collaboration is at the heart of everything we do. We’re actively connecting with Key Opinion Leaders in critical care, including Doctors, Nurses, Respiratory Therapists, and industry partners, to shape the future of airway management and infection prevention.
If you’re passionate about improving outcomes for ventilated patients or interested in partnering on research, clinical evaluation, or innovation in this space — we’d love to hear from you.